Options traders have piled into defensive positioning at a historic rate — and the divergence with an easing short book is the defining tension for SPY this week.
The put/call ratio jumped to 2.40 on May 12, a full 52-week high and more than three standard deviations above its 20-day mean of 1.95. That is the most extreme defensive skew in the past year by this measure. The spike came on a day when the ETF barely moved — down just 0.15% to $738.18 — which makes the demand for puts even more notable. Over the month, SPY has recovered sharply, up 8.6%, and the weekly gain of 2.0% reflects some of the market's relief after a punishing April. But the options market is not yet convinced the coast is clear.
Short interest tells a quieter story. At 11.5% of the free float — around 118 million shares — the short position is large in absolute terms but has been unwinding steadily. It is down about 2.1% over the week and 4.3% over the month, a slow but consistent retreat from the mid-April peak when shorts spiked above 11.9% during the worst of the sell-off. Borrow conditions confirm the de-escalation: cost to borrow has drifted down from 0.67% at the start of April to 0.36% now, and the lending market has gone from tight to comfortably loose. Availability, which tightened sharply as borrow demand surged through the April turbulence, has now eased dramatically — borrow is readily available at today's levels. The ORTEX short score has also slipped from near 50 in early May to 46.3, suggesting reduced conviction among those still positioned short.
The contrast between the easing short book and the surging PCR is the week's most interesting tension. When these two signals diverge, it often reflects a rotation in how participants are expressing bearish views — from outright shorting (which requires borrow) toward buying puts (which doesn't). That shift is consistent with the lending market loosening even as hedging demand reaches a new extreme. It also implies the skew is being driven more by institutional tail-risk hedging than by fresh directional bets.
On the institutional side, the holder base is dominated by large bank and trading firm holdings. JPMorgan's most recently reported position was 44.2 million shares, though it trimmed by over 5 million in Q4 2025. Morgan Stanley cut more aggressively — reducing its holding by 11.4 million shares in the same period to 28.8 million. Jane Street, by contrast, added 8.2 million shares in Q4 to reach 10.0 million. The divergence between the selling from traditional asset managers and the buying from market-making firms is a common pattern for SPY and reflects the ETF's dual life as both a long-term holding and a trading instrument.
What to watch next is whether the PCR spike normalises quickly — a one-day surge to a 52-week high that fades within the week would read as options expiry noise — or whether it persists, which would suggest institutional hedgers are building genuine tail cover into a market that has now retraced most of its April losses.
See the live data behind this article on ORTEX.
Open SPY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
